Business

As the dust settles following the U.S. Food and Drug Administration’s (FDA) recent regulations targeting compounding pharmacies, the landscape of weight-loss drugs like Eli Lilly’s Zepbound and diabetes medications such as Mounjaro appears murkier than ever. A striking fact remains: many compounding pharmacies continue to produce versions of these drugs even as the FDA has
0 Comments
PepsiCo’s recent decision to acquire the burgeoning prebiotic soda brand, Poppi, for an astounding $1.95 billion (with net costs effectively coming to $1.65 billion) begs a deep dive into the implications of this strategic move. As ordinary soda consumption continues to plummet, it’s imperative to question why the giant soda manufacturers are pivoting so dramatically.
0 Comments
The recent announcement from Delta Air Lines concerning its dismal first-quarter revenue forecasts reveals a significant shift in the travel industry’s dynamics, a trend that warrants grave consideration. Delta now projects a meager revenue increase of just 5% compared to the previous year, a stark decline from earlier forecasts that anticipated growth ranging from 6%
0 Comments